bendamustine hydrochloride has been researched along with Cytomegalovirus in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, T; Hamada, T; Hatta, Y; Iizuka, K; Iriyama, N; Koike, T; Kurihara, K; Miura, K; Nakagawa, M; Nakamura, H; Nakayama, T; Takahashi, H | 1 |
| Iwasaki, H; Kadowaki, M; Kohno, K; Takase, K; Yamasaki, S | 1 |
| Chiba, A; Kurokawa, M; Nakamura, F; Nakazaki, K | 1 |
| Goyle, S; Parikh, P; Singhania, SVK | 1 |
| Kawashima, I; Kirito, K; Mitsumori, T; Nakajima, K; Nozaki, Y; Sueki, Y; Yamamoto, T | 1 |
| Aisa, Y; Hasegawa, T; Nakazato, T; Shimazaki, K | 1 |
| Asano, C; Imai, Y; Inokuchi, K; Isono, N; Kazama, H; Masuda, M; Mitsuhashi, K; Moriya, K; Motoji, T; Shimura, H; Sugimori, H; Tamura, H; Tanaka, J; Watanabe, A | 1 |
| Boku, S; Hosoda, T; Kagoo, T; Ohashi, K; Ueno, H; Yamamoto, R; Yano, T; Yokoyama, A; Yoneda, M | 1 |
1 review(s) available for bendamustine hydrochloride and Cytomegalovirus
| Article | Year |
|---|---|
[Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Bendamustine Hydrochloride; Biomarkers; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Treatment Outcome; Valganciclovir; Virus Activation | 2014 |
1 trial(s) available for bendamustine hydrochloride and Cytomegalovirus
| Article | Year |
|---|---|
Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine.
Topics: Bendamustine Hydrochloride; CD4-CD8 Ratio; Cytomegalovirus; Humans; Lymphoma, B-Cell; Neoplasm Grading; Remission Induction; Risk Factors; Virus Activation | 2016 |
6 other study(ies) available for bendamustine hydrochloride and Cytomegalovirus
| Article | Year |
|---|---|
Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
Topics: Aged; Antiviral Agents; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Humans; Lymphoma; Retrospective Studies; Risk Factors | 2023 |
Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Humans; Injections, Intravenous; Intravitreal Injections; Japan; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Opportunistic Infections; Retrospective Studies | 2017 |
Cytomegalovirus antigenemia and end-organ disease in Japanese patients treated with bendamustine.
Topics: Aged; Aged, 80 and over; Antigens, Viral; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Virus Activation | 2018 |
CMV Pneumonitis following Bendamustine containing Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Pneumonia, Viral; Virus Activation | 2017 |
Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Nitrogen Mustard Compounds; Retrospective Studies; Virus Activation | 2015 |
Bendamustine can severely impair T-cell immunity against cytomegalovirus.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; T-Lymphocytes | 2013 |